Abstract:To improve the segmentation of diabetic retinopathy lesions (microaneurysms, hemorrhages, exudates, and soft exudates), we implemented a binary segmentation method specific to each type of lesion. As post-segmentation, we combined the individual model outputs into a single image to better analyze the lesion types. This approach facilitated parameter optimization and improved accuracy, effectively overcoming challenges related to dataset limitations and annotation complexity. Specific preprocessing steps included cropping and applying contrast-limited adaptive histogram equalization to the L channel of the LAB image. Additionally, we employed targeted data augmentation techniques to further refine the model's efficacy. Our methodology utilized the DeepLabv3+ model, achieving a segmentation accuracy of 99%. These findings highlight the efficacy of innovative strategies in advancing medical image analysis, particularly in the precise segmentation of diabetic retinopathy lesions. The IDRID dataset was utilized to validate and demonstrate the robustness of our approach.
Abstract:Diabetic retinopathy (DR) is a leading cause of blindness worldwide, underscoring the importance of early detection for effective treatment. However, automated DR classification remains challenging due to variations in image quality, class imbalance, and pixel-level similarities that hinder model training. To address these issues, we propose a robust preprocessing pipeline incorporating image cropping, Contrast-Limited Adaptive Histogram Equalization (CLAHE), and targeted data augmentation to improve model generalization and resilience. Our approach leverages the Swin Transformer, which utilizes hierarchical token processing and shifted window attention to efficiently capture fine-grained features while maintaining linear computational complexity. We validate our method on the Aptos and IDRiD datasets for multi-class DR classification, achieving accuracy rates of 89.65% and 97.40%, respectively. These results demonstrate the effectiveness of our model, particularly in detecting early-stage DR, highlighting its potential for improving automated retinal screening in clinical settings.